CD163 identifies a unique population of ramified microglia in HIV encephalitis (HIVE)

Eleanor S. Roberts, Eleizer Masliah, Howard S. Fox

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

The idea that CNS ramified microglia are quiescent has been challenged by studies that show that microglia without the classic signs of activation can be phagocytic and appear with shorter, thicker ramifications. These semi-activated cells may constitute a form of microglia that has not been previously recognized in neuropathological conditions and may contribute to the pathology and dysfunction in these disorders. This study investigated the expression of CD163, a cell surface marker whose normal expression is restricted to monocytes/macrophages, in cases of HIV or SIV encephalitis (HIVE/SIVE), Alzheimer disease, and variant Creutzfeldt-Jakob disease. In HIVE/SIVE, in addition to reacting with CNS macrophages, CD163 antibody staining was shown to highlight ramified microglia. Such reactivity was especially notable in grey matter ramified microglia and was greater than that of another typically used marker, HLA-DR. CD163 expression was only observed in infected/affected tissue, in contrast to that shown with another microglia marker, GLUT5, which has recently been shown to identify all microglia regardless of disease state. Although activated microglia were present in the other disorders, as evidenced by strong HLA-DR expression, there was very little CD163 immunoreactivity. The activation state identified by CD163 has not been previously recognized and may have a positive or negative impact on neuronal damage shown in HIV-associated dementia.

Original languageEnglish (US)
Pages (from-to)1255-1264
Number of pages10
JournalJournal of Neuropathology and Experimental Neurology
Volume63
Issue number12
DOIs
StatePublished - Dec 2004

Fingerprint

Microglia
Encephalitis
HIV
Population
HLA-DR Antigens
Macrophages
AIDS Dementia Complex
Creutzfeldt-Jakob Syndrome
Monocytes
Alzheimer Disease
Pathology
Staining and Labeling
Antibodies

Keywords

  • Alzheimer disease
  • CD163
  • HIVE
  • Microglia
  • SIVE
  • Variant Creutzfeldt-Jakob disease (vCJD)

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Neurology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Cite this

CD163 identifies a unique population of ramified microglia in HIV encephalitis (HIVE). / Roberts, Eleanor S.; Masliah, Eleizer; Fox, Howard S.

In: Journal of Neuropathology and Experimental Neurology, Vol. 63, No. 12, 12.2004, p. 1255-1264.

Research output: Contribution to journalArticle

@article{a089fc1226194648b94b39a3c5ce986e,
title = "CD163 identifies a unique population of ramified microglia in HIV encephalitis (HIVE)",
abstract = "The idea that CNS ramified microglia are quiescent has been challenged by studies that show that microglia without the classic signs of activation can be phagocytic and appear with shorter, thicker ramifications. These semi-activated cells may constitute a form of microglia that has not been previously recognized in neuropathological conditions and may contribute to the pathology and dysfunction in these disorders. This study investigated the expression of CD163, a cell surface marker whose normal expression is restricted to monocytes/macrophages, in cases of HIV or SIV encephalitis (HIVE/SIVE), Alzheimer disease, and variant Creutzfeldt-Jakob disease. In HIVE/SIVE, in addition to reacting with CNS macrophages, CD163 antibody staining was shown to highlight ramified microglia. Such reactivity was especially notable in grey matter ramified microglia and was greater than that of another typically used marker, HLA-DR. CD163 expression was only observed in infected/affected tissue, in contrast to that shown with another microglia marker, GLUT5, which has recently been shown to identify all microglia regardless of disease state. Although activated microglia were present in the other disorders, as evidenced by strong HLA-DR expression, there was very little CD163 immunoreactivity. The activation state identified by CD163 has not been previously recognized and may have a positive or negative impact on neuronal damage shown in HIV-associated dementia.",
keywords = "Alzheimer disease, CD163, HIVE, Microglia, SIVE, Variant Creutzfeldt-Jakob disease (vCJD)",
author = "Roberts, {Eleanor S.} and Eleizer Masliah and Fox, {Howard S.}",
year = "2004",
month = "12",
doi = "10.1093/jnen/63.12.1255",
language = "English (US)",
volume = "63",
pages = "1255--1264",
journal = "Journal of Neuropathology and Experimental Neurology",
issn = "0022-3069",
number = "12",

}

TY - JOUR

T1 - CD163 identifies a unique population of ramified microglia in HIV encephalitis (HIVE)

AU - Roberts, Eleanor S.

AU - Masliah, Eleizer

AU - Fox, Howard S.

PY - 2004/12

Y1 - 2004/12

N2 - The idea that CNS ramified microglia are quiescent has been challenged by studies that show that microglia without the classic signs of activation can be phagocytic and appear with shorter, thicker ramifications. These semi-activated cells may constitute a form of microglia that has not been previously recognized in neuropathological conditions and may contribute to the pathology and dysfunction in these disorders. This study investigated the expression of CD163, a cell surface marker whose normal expression is restricted to monocytes/macrophages, in cases of HIV or SIV encephalitis (HIVE/SIVE), Alzheimer disease, and variant Creutzfeldt-Jakob disease. In HIVE/SIVE, in addition to reacting with CNS macrophages, CD163 antibody staining was shown to highlight ramified microglia. Such reactivity was especially notable in grey matter ramified microglia and was greater than that of another typically used marker, HLA-DR. CD163 expression was only observed in infected/affected tissue, in contrast to that shown with another microglia marker, GLUT5, which has recently been shown to identify all microglia regardless of disease state. Although activated microglia were present in the other disorders, as evidenced by strong HLA-DR expression, there was very little CD163 immunoreactivity. The activation state identified by CD163 has not been previously recognized and may have a positive or negative impact on neuronal damage shown in HIV-associated dementia.

AB - The idea that CNS ramified microglia are quiescent has been challenged by studies that show that microglia without the classic signs of activation can be phagocytic and appear with shorter, thicker ramifications. These semi-activated cells may constitute a form of microglia that has not been previously recognized in neuropathological conditions and may contribute to the pathology and dysfunction in these disorders. This study investigated the expression of CD163, a cell surface marker whose normal expression is restricted to monocytes/macrophages, in cases of HIV or SIV encephalitis (HIVE/SIVE), Alzheimer disease, and variant Creutzfeldt-Jakob disease. In HIVE/SIVE, in addition to reacting with CNS macrophages, CD163 antibody staining was shown to highlight ramified microglia. Such reactivity was especially notable in grey matter ramified microglia and was greater than that of another typically used marker, HLA-DR. CD163 expression was only observed in infected/affected tissue, in contrast to that shown with another microglia marker, GLUT5, which has recently been shown to identify all microglia regardless of disease state. Although activated microglia were present in the other disorders, as evidenced by strong HLA-DR expression, there was very little CD163 immunoreactivity. The activation state identified by CD163 has not been previously recognized and may have a positive or negative impact on neuronal damage shown in HIV-associated dementia.

KW - Alzheimer disease

KW - CD163

KW - HIVE

KW - Microglia

KW - SIVE

KW - Variant Creutzfeldt-Jakob disease (vCJD)

UR - http://www.scopus.com/inward/record.url?scp=10044292902&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10044292902&partnerID=8YFLogxK

U2 - 10.1093/jnen/63.12.1255

DO - 10.1093/jnen/63.12.1255

M3 - Article

C2 - 15624762

AN - SCOPUS:10044292902

VL - 63

SP - 1255

EP - 1264

JO - Journal of Neuropathology and Experimental Neurology

JF - Journal of Neuropathology and Experimental Neurology

SN - 0022-3069

IS - 12

ER -